Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter B Bach

Showing results (61-70 of 202) with videos related to

Pageof 21
Sort By:
Journal of Oncology Practice|October 16, 2014
Improving outpatient oncology practice: several steps into a long journeyRena M Conti, Peter B Bach
JAMA|March 7, 2019
Prescription Drugs-List Price, Net Price, and the Rebate Caught in the MiddleStacie B Dusetzina, Peter B Bach
JAMA|November 20, 2018
Expansion of the Medicare 340B Payment Program: Hospital Participation, Prescribing Patterns and Reimbursement, and Legal ChallengesPeter B Bach, Rachel E Sachs
Health Affairs (Project Hope)|October 6, 2010
How Medicare could use comparative effectiveness research in deciding on new coverage and reimbursementSteven D Pearson, Peter B Bach
JAMA|December 1, 2015
Payer and Policy Maker Steps to Support Value-Based Pricing for DrugsPeter B Bach, Steven D Pearson
Onkologie|September 12, 2009
Adjuvant anthracyclines and taxanes: quantifying the costs of therapeutic advances in breast cancerPatrick G Morris, Peter B Bach
Seminars in Respiratory and Critical Care Medicine|April 19, 2011
Estimating individual risk for lung cancerCarol J Etzel, Peter B Bach
Journal of Oncology Practice|January 4, 2017
Physician's Office and Hospital Outpatient Setting in Oncology: It's About Prices, Not UsePeter B Bach, Raina H Jain
Journal of the National Cancer Institute|March 6, 2020
Use of Positron Emission Tomography Imaging: Another Nonbiological Source of Racial Disparities in US Cancer CareAaron P Mitchell, Peter B Bach
Annals of Internal Medicine|August 16, 2012
When the average applies to no one: personalized decision making about potential benefits of lung cancer screeningPeter B Bach, Michael K Gould
Pageof 21

Showing results (61-70 of 202) with videos related to

Sort By:
Pageof 21
Journal of Oncology Practice|October 16, 2014
Improving outpatient oncology practice: several steps into a long journeyRena M Conti, Peter B Bach
JAMA|March 7, 2019
Prescription Drugs-List Price, Net Price, and the Rebate Caught in the MiddleStacie B Dusetzina, Peter B Bach
JAMA|November 20, 2018
Expansion of the Medicare 340B Payment Program: Hospital Participation, Prescribing Patterns and Reimbursement, and Legal ChallengesPeter B Bach, Rachel E Sachs
Health Affairs (Project Hope)|October 6, 2010
How Medicare could use comparative effectiveness research in deciding on new coverage and reimbursementSteven D Pearson, Peter B Bach
JAMA|December 1, 2015
Payer and Policy Maker Steps to Support Value-Based Pricing for DrugsPeter B Bach, Steven D Pearson
Onkologie|September 12, 2009
Adjuvant anthracyclines and taxanes: quantifying the costs of therapeutic advances in breast cancerPatrick G Morris, Peter B Bach
Seminars in Respiratory and Critical Care Medicine|April 19, 2011
Estimating individual risk for lung cancerCarol J Etzel, Peter B Bach
Journal of Oncology Practice|January 4, 2017
Physician's Office and Hospital Outpatient Setting in Oncology: It's About Prices, Not UsePeter B Bach, Raina H Jain
Journal of the National Cancer Institute|March 6, 2020
Use of Positron Emission Tomography Imaging: Another Nonbiological Source of Racial Disparities in US Cancer CareAaron P Mitchell, Peter B Bach
Annals of Internal Medicine|August 16, 2012
When the average applies to no one: personalized decision making about potential benefits of lung cancer screeningPeter B Bach, Michael K Gould
Pageof 21